Es gab 50 kürzliche Insider-Transaktionen für Satsuma Pharmaceuticals, Inc. (STSA), darunter 34 Käufe und 15 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $55.79M und die gesamten Insider-Verkäufe auf $8.88M.
Bedeutende Insider mit kürzlicher Aktivität umfassen King Thomas Braxton, Kollins John A, Soloway Thomas P. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — STSA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-06-08 |
King Thomas Braxton |
Director |
Aktienrückgabe |
12,765 |
$0.90 |
$11.49K |
- |
| 2023-06-08 |
Kollins John A |
President and CEO |
Aktienrückgabe |
127,659 |
$0.90 |
$114.89K |
- |
| 2023-06-08 |
Soloway Thomas P |
Director |
Aktienrückgabe |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Lukatch Heath |
Director |
Aktienrückgabe |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Shah Rajeev M. |
10 Percent Owner |
Aktienrückgabe |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Sandoval Elisabeth |
Director |
Aktienrückgabe |
14,893 |
$4.56 |
$67.91K |
- |
| 2023-06-08 |
O'neil Thomas P. |
Chief Financial Officer |
Aktienrückgabe |
76,595 |
$1.04 |
$79.66K |
- |
| 2023-06-08 |
Takanashi Ken |
10 Percent Owner |
Aktienrückgabe |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Shin Nippon Biomedical Laboratories, Ltd. |
10 Percent Owner |
Informierter Kauf |
8,423,732 |
$0.91 |
$7.67M |
8,423,732 |
| 2023-06-08 |
Harsch Mutya |
Director |
Aktienrückgabe |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Riebe Michael T |
Director |
Aktienrückgabe |
12,765 |
$0.90 |
$11.49K |
- |
| 2023-06-08 |
Ra Capital Management, L.p. |
Officer |
Aktienrückgabe |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-06 |
Kollins John A |
President and CEO |
Übernahmeangebot (Verkauf) |
305,911 |
$0.91 |
$278.38K |
- |
| 2023-06-06 |
Shah Rajeev M. |
10 Percent Owner |
Übernahmeangebot (Verkauf) |
5,914,252 |
$0.91 |
$5.38M |
- |
| 2023-06-06 |
O'neil Thomas P. |
Chief Financial Officer |
Übernahmeangebot (Verkauf) |
13,877 |
$0.91 |
$12.63K |
- |
| 2023-06-06 |
Takanashi Ken |
10 Percent Owner |
Informierter Kauf |
22,053,581 |
$0.91 |
$20.07M |
24,847,694 |
| 2023-06-06 |
Shin Nippon Biomedical Laboratories, Ltd. |
10 Percent Owner |
Informierter Kauf |
22,053,581 |
$0.91 |
$20.07M |
22,053,581 |
| 2022-11-21 |
Leonard Braden Michael |
Director |
Informierter Kauf |
150,000 |
$0.71 |
$106.74K |
150,000 |
| 2022-11-15 |
Leonard Braden Michael |
Director |
Informierter Kauf |
531,000 |
$0.63 |
$336.71K |
6,139,306 |
| 2022-11-14 |
Leonard Braden Michael |
Director |
Unbekannt |
- |
- |
- |
5,608,306 |
| 2022-11-14 |
Leonard Braden Michael |
Director |
Informierter Kauf |
5,608,306 |
$0.69 |
$3.87M |
5,608,306 |
| 2022-11-14 |
Commodore Capital Lp |
Director |
Informierter Verkauf |
3,250,000 |
$0.71 |
$2.29M |
461,286 |
| 2022-06-03 |
Takanashi Ken |
Director |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
King Thomas Braxton |
Director |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
Albrecht Detlef |
Chief Medical Officer |
RSU-Zuteilung |
190,000 |
- |
- |
190,000 |
| 2022-06-03 |
Ra Capital Management, L.p. |
10 Percent Owner |
RSU-Zuteilung |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Kollins John A |
President and CEO |
RSU-Zuteilung |
505,000 |
$3.46 |
$1.75M |
505,000 |
| 2022-06-03 |
Soloway Thomas P |
Director |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
Lukatch Heath |
Director |
RSU-Zuteilung |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Shah Rajeev M. |
Director |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
Sandoval Elisabeth |
Director |
RSU-Zuteilung |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
O'neil Thomas P. |
Chief Financial Officer |
RSU-Zuteilung |
190,000 |
- |
- |
190,000 |
| 2022-06-03 |
Takanashi Ken |
Director |
RSU-Zuteilung |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Harsch Mutya |
Director |
RSU-Zuteilung |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Riebe Michael T |
Director |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2021-11-24 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
2,922 |
$5.42 |
$15.84K |
3,711,286 |
| 2021-11-22 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
9,979 |
$5.49 |
$54.78K |
3,708,364 |
| 2021-11-19 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
3,225 |
$5.44 |
$17.54K |
3,698,385 |
| 2021-11-11 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
7,941 |
$6.05 |
$48.04K |
3,695,160 |
| 2021-11-10 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
9,622 |
$5.85 |
$56.29K |
3,687,219 |
| 2021-11-08 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
560 |
$5.99 |
$3.35K |
3,677,597 |
| 2021-11-05 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
7,800 |
$5.95 |
$46.41K |
3,677,037 |
| 2021-11-04 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
1,400 |
$5.88 |
$8.23K |
3,669,237 |
| 2021-11-02 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
8,880 |
$5.64 |
$50.08K |
3,667,837 |
| 2021-10-29 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
44,651 |
$5.71 |
$254.96K |
3,658,957 |
| 2021-10-28 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
15,082 |
$5.55 |
$83.71K |
3,614,306 |
| 2021-10-27 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
39,581 |
$5.45 |
$215.72K |
3,599,224 |
| 2021-10-22 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
27,629 |
$5.51 |
$152.24K |
3,559,643 |
| 2021-10-21 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
32,816 |
$5.40 |
$177.21K |
3,532,014 |
| 2021-10-20 |
Commodore Capital Lp |
10 Percent Owner |
Informierter Kauf |
40,663 |
$5.44 |
$221.21K |
3,499,198 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
